新关注 > 信息聚合 > 医药业超级并购硝烟又起 默克 艾尔健或争购Biogen

医药业超级并购硝烟又起 默克 艾尔健或争购Biogen

Super pharmaceutical industry mergers and acquisitions smoke underway Merck Ayer health or snapping Biogen

2016-08-03 17:00:15来源: 全景网

虽然辉瑞(Pfizer)并购艾尔健(Allergan)的史上最大药企并购三个月前告吹,但制药业的并购声浪并未偃旗息鼓。外媒获悉,默克(Merck)和艾尔健都有意收购美国生物制药巨头Biogen。 ...

Although the history of the former Pfizer (Pfizer) acquisition of El Kin (Allergan) is the largest pharmaceutical merger fell through three months, but the wave of mergers and acquisitions in the pharmaceutical industry has not died down. Foreign media was informed Merck (Merck) and Al Kin are interested in buying US biopharmaceutical giant Biogen. ...